United States Biotechnology & Medical Research

Emerald Bioscience Inc (EMBI)

Track

Ticker: EMBI Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 22 Aug 2025
Value US$381,157.15 | Price 83.34 | Shares 48,267 (+4.6%)
Sale 22 Aug 2025
Value US$4,757,506.86 | Price 121.72 | Shares 29,923 (+47.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
48,267 +4.6%
83.34
US$381,157 		48,267 +4.6% 83.34 US$381,157
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
29,923 +47.0%
121.72
US$4,757,507 		29,923 +47.0% 121.72 US$4,757,507
2025-08-22 2025-08-22 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
31,156 -36.0%
45.84
US$4,064,132 		31,156 -36.0% 45.84 US$4,064,132
2025-08-22 2025-08-22 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
163,979 -10.1%
3.42
US$560,808 		163,979 -10.1% 3.42 US$560,808
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2025-08-22 2025-08-21 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2024-11-20 2024-11-18 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
19,489 -19.2%
4.99
US$97,250 		19,489 -19.2% 4.99 US$97,250
2024-11-19 2024-11-18 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
43,206 -20.6%
4.99
US$215,598 		43,206 -20.6% 4.99 US$215,598
2024-11-19 2024-11-18 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
82,546 -20.0%
4.99
US$411,905 		82,546 -20.0% 4.99 US$411,905
2024-11-19 2024-11-18 S Sale
Grayson Paul A.
Non-Executive Director
86,244 -24.9%
4.99
US$430,358 		86,244 -24.9% 4.99 US$430,358
2024-11-20 2024-11-15 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
85 -0.1%
5.55
US$472 		85 -0.1% 5.55 US$472
2024-11-19 2024-11-15 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
190 -0.1%
5.55
US$1,054 		190 -0.1% 5.55 US$1,054
2024-11-19 2024-11-15 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
364 -0.1%
5.55
US$2,020 		364 -0.1% 5.55 US$2,020
2024-11-19 2024-11-15 S Sale
Grayson Paul A.
Non-Executive Director
307 -0.1%
5.55
US$1,704 		307 -0.1% 5.55 US$1,704
2024-11-15 2024-11-15 PrS Proposed sale
ARSENAULT KAITLYN

Officer

Officer
57,084
5.51
US$314,533 		57,084 5.51 US$314,533
2024-11-15 2024-11-15 PrS Proposed sale
DHILLON PUNIT

Officer; Director

Executive Director
100,693
5.51
US$554,818 		100,693 5.51 US$554,818
2024-11-15 2024-11-15 PrS Proposed sale
Diep Tuan Tu

Officer

Officer
22,877
5.51
US$126,052 		22,877 5.51 US$126,052
2024-11-15 2024-11-15 PrS Proposed sale
Grayson Paul A.

Director

Non-Executive Director
86,804
5.51
US$478,290 		86,804 5.51 US$478,290
2024-09-13 2024-09-13 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-11 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
1.1
Schwab Andrew J.
Non-Executive Director Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-03-15 2024-03-13 B Purchase
5AM Partners VII, LLC
Large shareholder
450,000 +5.7%
10.00
US$4,500,000 		450,000 +5.7% 10.00 US$4,500,000
2024-02-02 2024-01-31 B Purchase
5AM Partners VII, LLC
Large shareholder
5,206,074 +190.2%
2.31
US$12,026,031 		5,206,074 +190.2% 2.31 US$12,026,031
2023-08-29 2023-08-29 B Purchase
DHILLON PUNIT

Chief Executive Officer

Executive Director
881,000 +2.2%
0.02
US$16,475 		881,000 +2.2% 0.02 US$16,475
2018-02-21 2018-02-16 B Purchase Emerald Health Sciences Inc. Large shareholder
15,000,000
0.00
US$0 		15,000,000 0.00 US$0
2015-04-10 2015-04-10 S Sale Ladin Brian D Large shareholder
11,830 -4.5%
4.93
US$58,310 		11,830 -4.5% 4.93 US$58,310
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
15,800 -5.7%
4.79
US$75,682 		15,800 -5.7% 4.79 US$75,682
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
23,000 -7.7%
4.69
US$107,893 		23,000 -7.7% 4.69 US$107,893
Explore more

More insider trading research around Emerald Bioscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America